-
公开(公告)号:US11529440B2
公开(公告)日:2022-12-20
申请号:US16847272
申请日:2020-04-13
申请人: Surmodics, Inc.
发明人: Joram Slager , Toni M. Heyer , David E. Babcock
IPC分类号: A61L29/08 , A61L29/16 , A61L29/14 , A61K31/337 , A61K31/713 , A61K47/34 , A61M25/10 , C12N15/113 , A61K9/50
摘要: Embodiments of the invention include drug delivery coatings and devices including the same. In an embodiment, the invention includes a drug delivery coating including a polymeric layer. The polymeric layer can include a hydrophilic outer surface. The coating can also include a matrix contacting the hydrophilic outer surface. The matrix can include a particulate hydrophobic therapeutic agent and a cationic agent. The polymeric layer can further include a hydrophilic polymer having pendent photoreactive groups and a photo-crosslinker including two aryl ketone functionalities. Other embodiments are also included herein.
-
公开(公告)号:US09999675B2
公开(公告)日:2018-06-19
申请号:US15357496
申请日:2016-11-21
申请人: Surmodics, Inc.
发明人: Joseph Ventura , Shannon Wadman , Joram Slager , Joseph Schmidt McGonigle , Robert W. Hergenrother
CPC分类号: A61K47/34 , A61K9/0019 , A61K9/08 , A61K31/337 , A61L27/18 , A61L27/54 , A61L2300/416 , A61L2300/63 , A61L2400/06 , C08L79/02
摘要: Disclosed herein is a delivery composition for administering a hydrophobic active agent. In one embodiment, a delivery composition for local administration of a hydrophobic active agent to a tissue or organ of a patient is disclosed. In one embodiment, the delivery composition includes a cationic delivery agent, a therapeutically effective amount of a hydrophobic active agent and a pharmaceutically acceptable aqueous carrier. In one embodiment, the cationic delivery agent includes polyethyleneimine (PEI). In a more specific embodiment, the cationic delivery agent includes branched PEI. Methods of making the delivery composition, as well as kits and methods of use are also disclosed.
-
3.
公开(公告)号:US09949957B2
公开(公告)日:2018-04-24
申请号:US15262465
申请日:2016-09-12
申请人: Surmodics, Inc.
发明人: Joram Slager
IPC分类号: A61K31/436 , A61K9/00 , A61K9/107 , A61K9/19 , A61K9/51 , A61L29/08 , A61L29/16 , A61K9/14 , A61K9/16
CPC分类号: A61K31/436 , A61K9/0019 , A61K9/1075 , A61K9/145 , A61K9/1688 , A61K9/19 , A61K9/5123 , A61K9/5138 , A61K9/5146 , A61L29/085 , A61L29/16 , Y02A50/402 , Y02A50/478 , Y10T428/2982
摘要: The disclosure provides macrolide particulates including a macrolide therapeutic agent such as rapamycin at high concentration in the particulate. In one method the particulates are made by adding a composition containing an polyoxyethylene sorbitan n-acyl ester, poly(ethyleneimine), or alkylated quaternary ammonium salt to a composition including macrolide dissolved in an alcohol such as ethanol. In another method the particulates are made by adding a non-solvent composition to a composition including macrolide and an alkyl-substituted chromanol dissolved in an alcohol such as ethanol. The formed macrolide particulates have one or more desirable properties including sizes in the range of 0.1 μm to 10 μm, spherical or near spherical shapes, low polydispersity, and/or stability. The macrolide particulates can be used for therapeutic compositions, or in association with an implantable or insertable medical device, such as associated with a polymeric coating on a device.
-
公开(公告)号:US09155671B2
公开(公告)日:2015-10-13
申请号:US14055654
申请日:2013-10-16
申请人: SurModics, Inc.
发明人: Shawn Fuller , Bryan A. Claseman , Joram Slager , Jeffrey J. Missling , Gary Maharaj , Gary W. Opperman , Nathan Lockwood , Robert W. Hergenrother , Charles Olson
CPC分类号: A61F13/00068 , A61F13/00021 , A61F13/00029 , A61F13/8405 , A61F2013/00153 , A61F2013/00327 , A61F2013/00331 , A61F2013/00357 , A61F2013/00557 , A61L15/22 , A61L15/44 , A61L15/60 , A61L2300/102 , A61L2300/208
摘要: Embodiments of the invention include wound packing devices and methods of making and using the same. In an embodiment, the invention includes a wound packing device including a plurality of spacing elements capable of absorbing exudate, wherein the surface of the spacing elements resist colonization by microorganisms. The wound packing device can also include a connector connecting the plurality of spacing elements to one another. Other embodiments are also included herein.
摘要翻译: 本发明的实施例包括伤口包装装置及其制造和使用方法。 在一个实施方案中,本发明包括包含能够吸收渗出物的多个间隔元件的伤口包装装置,其中间隔元件的表面抵抗微生物的定居。 卷绕包装装置还可以包括将多个间隔元件彼此连接的连接器。 本文还包括其它实施例。
-
公开(公告)号:US11174447B2
公开(公告)日:2021-11-16
申请号:US16505145
申请日:2019-07-08
申请人: Surmodics, Inc.
IPC分类号: B32B27/30 , A61L27/34 , A61L27/28 , A61L31/10 , A61L31/08 , A61L29/08 , C10M107/26 , C10M107/46 , C10M107/42 , A61M25/10 , B32B27/00 , C10N40/00 , C10N50/08
摘要: Embodiments herein include coated medical devices and coatings with salt groups. In an embodiment, a coated medical device is included, the coated medical device including a substrate and a polymeric layer disposed over the substrate. The polymeric layer includes a polymer and has an exterior surface. The coated medical device further includes a plurality of salt groups bonded to the polymer of the polymeric layer and disposed on the exterior surface of the polymeric layer. The salt groups can be the reaction product of a reactive group with an acid or base. In an embodiment, a method of making a medical device is included. Other embodiments are also included herein.
-
公开(公告)号:US10806904B2
公开(公告)日:2020-10-20
申请号:US15467554
申请日:2017-03-23
申请人: Surmodics, Inc.
摘要: Embodiments herein include an insertion tool for inserting a medical device into another medical device, such as a hemostasis sealing valve, and related methods. In an embodiment, an insertion tool includes a guide sheath and a protection tube. The guide sheath can include a flared proximal end. The guide sheath can further include a central lumen. The guide sheath can further include a locking notch disposed on the inner surface between the proximal end and the distal end. The protection tube can include a flared proximal end. A portion of the protection tube can be situated within the central lumen of the guide sheath. The flared proximal end of the protection tube can be sized to fit within the locking notch and can have an outer diameter larger than portions of the inner surface immediately adjacent to the locking notch. Other embodiments are also included herein.
-
公开(公告)号:US10342898B2
公开(公告)日:2019-07-09
申请号:US15375442
申请日:2016-12-12
申请人: Surmodics, Inc.
摘要: Embodiments herein include coated medical devices and coatings with salt groups. In an embodiment, a coated medical device is included, the coated medical device including a substrate and a polymeric layer disposed over the substrate. The polymeric layer includes a polymer and has an exterior surface. The coated medical device further includes a plurality of salt groups bonded to the polymer of the polymeric layer and disposed on the exterior surface of the polymeric layer. The salt groups can be the reaction product of a reactive group with an acid or base. In an embodiment, a method of making a medical device is included. Other embodiments are also included herein.
-
8.
公开(公告)号:US20180303803A1
公开(公告)日:2018-10-25
申请号:US15959589
申请日:2018-04-23
申请人: Surmodics, Inc.
发明人: Joram Slager
IPC分类号: A61K31/436 , A61K9/16 , A61K9/14 , A61L29/16 , A61L29/08 , A61K9/51 , A61K9/19 , A61K9/107 , A61K9/00
CPC分类号: A61K31/436 , A61K9/0019 , A61K9/1075 , A61K9/145 , A61K9/1688 , A61K9/19 , A61K9/5123 , A61K9/5138 , A61K9/5146 , A61L29/085 , A61L29/16 , Y02A50/402 , Y02A50/478 , Y10T428/2982
摘要: The disclosure provides macrolide particulates including a macrolide therapeutic agent such as rapamycin at high concentration in the particulate. In one method the particulates are made by adding a composition containing an polyoxyethylene sorbitan n-acyl ester, poly(ethyleneimine), or alkylated quaternary ammonium salt to a composition including macrolide dissolved in an alcohol such as ethanol. In another method the particulates are made by adding a non-solvent composition to a composition including macrolide and an alkyl-substituted chromanol dissolved in an alcohol such as ethanol. The formed macrolide particulates have one or more desirable properties including sizes in the range of 0.1 μm to 10 μm, spherical or near spherical shapes, low polydispersity, and/or stability. The macrolide particulates can be used for therapeutic compositions, or in association with an implantable or insertable medical device, such as associated with a polymeric coating on a device.
-
公开(公告)号:US20170072129A1
公开(公告)日:2017-03-16
申请号:US15257252
申请日:2016-09-06
申请人: Surmodics, Inc.
发明人: Joram Slager , Joe McGonigle , Anh Tri La , David E. Babcock , Bruce Jelle , Aleksey Kurdyumov , Timothy M. Kloke , Charlie Olson , Gary Maharaj , Nathan Lockwood
摘要: A hemodialysis vascular access device includes a proximal end sized and shaped to sealably couple to a hemodialysis catheter, a movable structure coupled to the proximal end, a fixation structure coupled to the movable region and sized and shaped for fixation on a patient, an elongated sleeve coupled to the fixation structure and sized and shaped for insertion into a patient's vasculature, and a valve at a distal end of the internal lumen. When a hemodialysis catheter is inserted into the device and coupled to the proximal end, distal movement of the proximal end relative to the fixation structure biases a distal end of the hemodialysis catheter from a position inside the elongated sleeve through a valve out of the device and into the patient's blood.
摘要翻译: 血液透析血管通路装置包括尺寸和形状可密封地连接到血液透析导管的近端,耦合到近端的可移动结构,联接到可移动区域的尺寸和形状用于固定在患者身上的细长套筒 耦合到所述固定结构,并且其尺寸和形状用于插入到患者的脉管系统中,以及在所述内腔的远端处的阀。 当血液透析导管插入装置并且联接到近端时,近端相对于固定结构的远端运动通过穿过装置的阀将细胞套筒内的位置偏离血液透析导管的远端, 进入病人的血液。
-
公开(公告)号:US11123459B2
公开(公告)日:2021-09-21
申请号:US15842110
申请日:2017-12-14
申请人: Surmodics, Inc.
发明人: Joram Slager , Rick Murphy
摘要: Drug delivery coatings and devices including the same are described herein. The drug delivery coating has a first coated layer with non-ionic polymer and photogroups, a second coated layer with acid polymer in contact and hydrogen bonded with the first layer, particles with hydrophobic therapeutic agent, and cationic agent. The coating can be provided on a balloon catheter, and the particles and cationic agent can be transferred to tissue during a medical procedure, such as an angioplasty procedure, for a therapeutic effect.
-
-
-
-
-
-
-
-
-